CEACAM5 and colorectal carcinoma: Furthermore, CEA serum levels have been also found increased in CRC patients in comparison to healthy individuals, which was also associated with a poor prognosis of the disease, demonstrating that the measurement of CEA levels in serum is not useful for the early diagnosis of the disease, but as a prognostic biomarker of CRC (123–126).